Stay updated on Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of study content. This indicates an access restriction or site issue preventing loading of the record.
    Difference
    17%
    Check dated 2026-09-23T20:22:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a site-level update; no changes to the study information or its presentation are reflected in this diff.
    Difference
    0.1%
    Check dated 2026-09-16T20:04:31.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision tag in the footer updated from v3.6.5 to v3.6.6, indicating a new build of the site. This behind-the-scenes update is related to the page version and does not modify the study details.
    Difference
    0.1%
    Check dated 2026-09-02T19:37:34.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page shows a revised revision label, updating from v3.6.4 to v3.6.5 to reflect a minor backend update to the site.
    Difference
    0.1%
    Check dated 2026-08-12T09:27:20.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the prior Revision: v3.6.3, indicating an updated site or document version.
    Difference
    0.1%
    Check dated 2026-07-28T15:40:40.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and the previous Revision: v3.6.0 was removed. This indicates the page's version was updated.
    Difference
    0.1%
    Check dated 2026-06-30T01:17:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.